Jennifer Ruddock | Head of Corporate Affairs |
Howard Robin | President and CEO |
Gil Labrucherie | COO and CFO |
Jonathan Zalevsky | Chief of Research and Development |
Dimitry Nuyten | Chief Medical Officer |
Jay Olson | Oppenheimer |
Jessica Fye | JPMorgan |
Daina Graybosch | SVB Leerink |
Arlinda Lee | Canaccord |
Good day and thank you for standing by. Welcome to the Nektar Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session [Operator Instructions] Please be advised that today's conference may be recorded. [Operator Instructions] I'd now like to hand the conference over to your speaker today, Jennifer Ruddock, Head of Corporate Affairs.